Characteristics of clinician input in Canadian funding decisions for cancer drugs: a cross-sectional study based on CADTH reimbursement recommendations

OBJECTIVE: To examine characteristics of clinician input to the pan-Canadian Oncology Drug Review (pCODR) for cancer drug funding recommendations from 2016 to 2020. DESIGN, SETTING AND PARTICIPANTS: Descriptive, cross-sectional study including 62 reimbursement decisions from pCODR from 2016 to 2020....

Descripción completa

Detalles Bibliográficos
Autores principales: Jenei, Kristina, Meyers, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583055/
https://www.ncbi.nlm.nih.gov/pubmed/37844982
http://dx.doi.org/10.1136/bmjopen-2022-066378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583055/
https://www.ncbi.nlm.nih.gov/pubmed/37844982
http://dx.doi.org/10.1136/bmjopen-2022-066378

Ejemplares similares